Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
复制标题
DOI：
10.1155/2015/487159
复制
发表时间：
2015
影响因子：
2.5
通讯作者：
Raoof M
中科院分区：
文献类型：
--
作者：
Alsaadi T;El Hammasi K;Shahrour TM;Shakra M;Turkawi L;Mudhafar A;Diab L;Raoof M
据报道，多发性硬化症患者普遍存在抑郁和焦虑，患病率从20%到50%不等。不幸的是，发病率、模式和风险因素在我们中东地区没有得到很好的研究，据我们所知，在阿联酋根本没有。使用标准化筛查工具，我们观察到在MS诊所就诊的80名患者中，分别有17%和20%的患者得分与重度抑郁症和焦虑症一致，与年龄和性别匹配的对照组相比，这一比例没有统计学差异。包括疾病持续时间、EDSS评分、年龄、性别和教育水平在内的研究变量与两种疾病的发生率均无显著相关性。几乎三分之二的得分与严重抑郁和焦虑相符的患者没有服用抗抑郁药和抗焦虑药物。
Depression and anxiety are reported to be prevalent in patients with MS, with prevalence rates ranging from 20% to 50%. Unfortunately, the rates, patterns, and risk factors are not well studied in our Middle East region, and, to our knowledge, not at all in UAE. Using standardized screening tools, we observed that 17% and 20% of 80 patients seen in MS clinic had scores consistent with major depression and anxiety disorders, respectively, at a rate that was not statistically different when compared to age and sex matched controls. None of the studied variables including duration of the disease, EDSS scores, age, gender, and the level of education had any significant correlation with the rates of both disorders. Almost two-thirds of the patients with scores consistent with major depression and anxiety were not on antidepressant and antianxiety medications.